Hallal David

Scholar Rock CEO Hallal David sold 30,615 shares at $49.57 on 2026-04-16; stock now $47.80, down from 52-week high of $50.01.

David sold 30,615 shares (1.8% of pre-transaction holdings) at $49.57, near the 52-week high of $50.01, while the stock has since declined to $47.80. His cross-ticker track record shows 75.00% well-timed sell performance across 4 prior transactions, but at Scholar Rock specifically, his prior sell on 2026-01-13 was poorly timed, with the stock rising 16.0% in the 90-day period following that sale. Scholar Rock faces structural headwinds: the company posted -$102.2M net income on $33.2M quarterly revenue and reported -100.0% annual revenue growth, indicating a significant business contraction or major earnings miss. The timing of this sale near a 52-week peak, combined with the company's deteriorating fundamentals, warrants investor attention to near-term disclosure and capital allocation decisions.

CEO Hallal David sold 57,450 shares of SRRK at $42.70 (Jan 13); holdings now 1,541,645 shares; stock up 66.5% in 90 days despite $-102.2M net loss.

Hallal David, the CEO, sold 57,450 shares for $2,453,115.00, reducing his stake by 3.6% to 1,541,645 shares. This sale occurred at $42.70, notably below the current price of $46.53 and the 52-week high of $46.87, placing the transaction in the upper half of recent trading range despite the stock's +5.0% gain over the prior 30 days and +66.5% surge over 90 days. The company remains unprofitable with a net income of $-102.2M against revenue of $33.2M, though it showed robust 76.4% annual revenue growth. Across his cross-ticker track record, Hallal's prior three sales averaged -1.5% returns over 90 days with a 100.00% well-timed rate, suggesting his historical sells have coincided with subsequent stock weakness; however, this timing pattern cannot be attributed to skill in a discretionary context and warrants monitoring against forward fundamentals and broader market conditions.

iTeos director David Hallal exits entire position with 3 sales of 114.7K shares totaling $1.2M at blended $10.15 average.

Director Hallal David completed a full liquidation of his 114,682 shares at iTeos across three consecutive trading days (June 4–6, 2025), with transaction prices ranging from $10.07 to $10.24 and a blended average of $10.15. The complete sale of his entire stake is notable given that iTeos is unprofitable with net income of $-34,613,000 and generated zero revenue in the latest quarter, though the company did report annual revenue growth of +177.9% year-over-year. The stock has recovered significantly in the short term (+57.9% over 30 days, +44.3% over 90 days) but remains -43.4% below its 52-week high of $17.97, and is trading at $10.17 at the time of filing, essentially at the exit prices. The total elimination of the director's holding signals a meaningful change in his ownership position and warrants investor attention given the company's pre-revenue clinical-stage profile.